Regression or Reduction in Progression of Atherosclerosis, and Avoidance of Coronary Events, With Lovastatin in Patients With or at High Risk of Cardiovascular Disease: A Review

Author： Frisinghelli Anna  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.27, Iss.9, 2007-01, pp. : 591-604

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Relationship Between Cigarette Smoking and Other Coronary Risk Factors in Atherosclerosis: Risk of Cardiovascular Disease and Preventive Measures

By  

Current Pharmaceutical Design, Vol. 9, Iss. 29, 2003-11 ,pp. : 2417-2423

Bentham Science Publishers

Access to resources Recommend Favorite

Ramipril cost effective in patients at high risk for cardiovascular events

By  

Inpharma, Vol. 1, Iss. 1460, 2004-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Ramipril cost effective in patients at high risk for cardiovascular events

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 464, 2004-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Prescribing of bicalutamide should be restricted to patients at high risk of disease progression

By  

Reactions Weekly, Vol. 1, Iss. 1154, 2007-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Ranolazine dose not reduce the risk of major cardiovascular events in patients with acute coronary syndromes

By  

Inpharma, Vol. 1, Iss. 1586, 2007-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite